Clinical Trial Update: Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Abraxane (nab-paclitaxel) plus hormonal therapy as initial treatment for unresectable or metastatic prostate cancer; the study has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Hormonal Therapy

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prostatic Neoplasms | Phase 2 | Status: TERMINATED